Loading...

Liquidia Corporation

LQDANASDAQ
Healthcare
Biotechnology
$24.10
$0.00(0.00%)

Liquidia Corporation (LQDA) Stock Competitors & Peer Comparison

See (LQDA) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LQDA$24.10+0.00%2.2B-14.74-$1.71N/A
VRTX$387.77+0.00%101.5B28.20$14.04N/A
REGN$556.55-0.00%58.5B14.15$39.68+0.32%
ALNY$429.93+0.00%56.7B-174.40-$2.48N/A
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ARGX$637.56+0.00%39.6B32.89$19.66N/A
BNTX$111.00+0.00%27.1B-67.94-$1.66N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
SMMT$25.69+0.02%20B-26.60-$1.01N/A
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LQDA vs VRTX Comparison August 2025

LQDA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LQDA stands at 2.2B. In comparison, VRTX has a market cap of 101.5B. Regarding current trading prices, LQDA is priced at $24.10, while VRTX trades at $387.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LQDA currently has a P/E ratio of -14.74, whereas VRTX's P/E ratio is 28.20. In terms of profitability, LQDA's ROE is -1.58%, compared to VRTX's ROE of +0.22%. Regarding short-term risk, LQDA is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for LQDA.Check VRTX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;